Activation of distinct inflammatory pathways in subgroups of LR-MDS.
Journal Information
Full Title: Leukemia
Abbreviation: Leukemia
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests KHM served as a consultant and received honoraria from Novartis. CT is co-owner and CEO of AgenDix GmbH, a company performing molecular diagnostics. JiW, JaW and AB are employees of Novartis. UP received research support and honoraria from Novartis. All other authors declare no potential conflicts of interest."
Funding Disclosure
Evidence found in paper:
"Funding Open Access funding enabled and organized by Projekt DEAL."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025